2 1 Shi Ji Jing Ji Bao Dao·2025-10-17 00:04Core Insights - Asset management institutions have shown a decline in enthusiasm for researching listed companies in Q3, with a 24.8% decrease in the number of companies surveyed compared to the previous quarter [1] - In contrast, during Q2, there was a significant increase of 49.31% in the number of companies surveyed as the market experienced a period of stagnation [1] - The focus of asset management institutions remains on technology stocks, with a growing interest in pharmaceutical and medical stocks [2] Group 1: Research Activity - In the first three quarters, insurance asset management companies conducted 7,687 surveys on 5,850 individual stocks, with a majority focused on Shenzhen Main Board and Sci-Tech Innovation Board, accounting for 26.92% and 25.91% respectively [2] - The most active insurance asset management company, Taikang Asset, surveyed 860 companies, focusing primarily on the Shanghai Main Board [2] - Broker asset management companies surveyed 4,216 times, with 3,321 individual stocks, showing a preference for high-growth potential and technology-intensive companies [2][3] Group 2: Sector Preferences - In Q3, the Sci-Tech 50 index rose by 49.02%, significantly outperforming the Shanghai and Shenzhen 300 index, which increased by 17.9% [4] - Insurance asset management companies surveyed 600 companies on the Sci-Tech Innovation Board in Q3, making it the most surveyed sector, followed by the Shenzhen Main Board [4] - The most favored stocks among research institutions in Q3 included Mindray Medical, with 538 institutions conducting surveys, followed by Huichuan Technology and Maiwei Biomedical [5]